|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Treiber T, Treiber N and Meister G:
Regulation of microRNA biogenesis and function. Thromb Haemost.
107:605–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anglicheau D, Muthukumar T and
Suthanthiran M: MicroRNAs: small RNAs with big effects.
Transplantation. 90:105–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20.
2013.PubMed/NCBI
|
|
5
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. In: Proc Natl Acad Sci USA. 105. pp. 10513–10518. 2008;
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ng EK, Chong WW, Jin H, et al:
Differential expression of microRNAs in plasma of patients with
colorectal cancer: a potential marker for colorectal cancer
screening. Gut. 58:1375–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang HJ, Ruan HJ, He XJ, et al:
MicroRNA-101 is down-regulated in gastric cancer and involved in
cell migration and invasion. Eur J Cancer. 46:2295–2303. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yao Y, Suo AL, Li ZF, et al: MicroRNA
profiling of human gastric cancer. Mol Med Rep. 2:963–970.
2009.PubMed/NCBI
|
|
9
|
Ambros V: MicroRNA pathways in flies and
worms: growth, death, fat, stress and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rachagani S, Kumar S and Batra SK:
MicroRNA in pancreatic cancer: pathological, diagnostic and
therapeutic implications. Cancer Lett. 292:8–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu R, Zhang C, Hu Z, et al: A
five-microRNA signature identified from genome-wide serum microRNA
expression profiling serves as a fingerprint for gastric cancer
diagnosis. Eur J Cancer. 47:784–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiong Y, Fang JH, Yun JP, et al: Effects
of MicroRNA-29 on apoptosis, tumorigenicity, and prognosis of
hepatocellular carcinoma. Hepatology. 51:836–845. 2010.PubMed/NCBI
|
|
13
|
Synnergren J, Améen C, Lindahl A, et al:
Expression of microRNAs and their target mRNAs in human stem
cell-derived cardiomyocyte clusters and in heart tissue. Physiol
Genomics. 43:581–594. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lovat F, Valeri N and Croce CM: MicroRNAs
in the pathogenesis of cancer. Semin Oncol. 38:724–733. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Simon R: Challenges of microarray data and
the evaluation of gene expression profile signatures. Cancer
Invest. 26:327–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z, Cao Y, Jie Z, et al: miR-495 and
miR-551a inhibit the migration and invasion of human gastric cancer
cells by directly interacting with PRL-3. Cancer Lett. 323:41–47.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yin VP, Lepilina A, Smith A and Poss KD:
Regulation of zebrafish heart regeneration by miR-133. Dev Biol.
365:319–327. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen JF, Mandel EM, Thomson JM, et al: The
role of microRNA-1 and microRNA-133 in skeletal muscle
proliferation and differentiation. Nat Genet. 38:228–233. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Y, Wu D, Tao J, et al: MicroRNA-133
inhibits cell proliferation, migration and invasion by targeting
epidermal growth factor receptor and its downstream effector
proteins in bladder cancer. Scand J Urol. 47:423–432. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tao J, Wu D, Xu B, et al: MicroRNA-133
inhibits cell proliferation, migration and invasion in prostate
cancer cells by targeting the epidermal growth factor receptor.
Oncol Rep. 27:1967–1975. 2012.PubMed/NCBI
|
|
22
|
Kinoshita T, Nohata N, Watanabe-Takano H,
et al: Actin-related protein 2/3 complex subunit 5 (ARPC5)
contributes to cell migration and invasion and is directly
regulated by tumor-suppressive microRNA-133a in head and neck
squamous cell carcinoma. Int J Oncol. 40:1770–1778. 2012.PubMed/NCBI
|
|
23
|
Moriya Y, Nohata N, Kinoshita T, et al:
Tumor suppressive microRNA-133a regulates novel molecular networks
in lung squamous cell carcinoma. J Hum Genet. 57:38–45. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kawakami K, Enokida H, Chiyomaru T, et al:
The functional significance of miR-1 and miR-133a in renal cell
carcinoma. Eur J Cancer. 48:827–836. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu ZS, Wang CQ, Xiang R, et al: Loss of
miR-133a expression associated with poor survival of breast cancer
and restoration of miR-133a expression inhibited breast cancer cell
growth and invasion. BMC Cancer. 12:512012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu J, Lu KH, Liu ZL, et al: MicroRNA-100
is a potential molecular marker of non-small cell lung cancer and
functions as a tumor suppressor by targeting polo-like kinase 1.
BMC Cancer. 12:5192012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li BH, Zhou JS, Ye F, et al: Reduced
miR-100 expression in cervical cancer and precursors and its
carcinogenic effect through targeting PLK1 protein. Eur J Cancer.
47:2166–2174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng DX, Luo M, Qiu LW, et al: Prognostic
implications of microRNA-100 and its functional roles in human
epithelial ovarian cancer. Oncol Rep. 27:1238–1244. 2012.PubMed/NCBI
|
|
29
|
Zheng YS, Zhang H, Zhang XJ, et al:
MiR-100 regulates cell differentiation and survival by targeting
RBSP3, a phosphatase-like tumor suppressor in acute myeloid
leukemia. Oncogene. 31:80–92. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun Q, Zhang J, Cao W, et al: Dysregulated
miR-363 affects head and neck cancer invasion and metastasis by
targeting podoplanin. Int J Biochem Cell Biol. 45:513–520. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Georgieva B, Milev I, Minkov I, et al:
Characterization of the uterine leiomyoma microRNAome by deep
sequencing. Genomics. 99:275–281. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Georges SA, Biery MC, Kim SY, et al:
Coordinated regulation of cell cycle transcripts by p53-Inducible
microRNAs, miR-192 and miR-215. Cancer Res. 68:10105–10112. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song B, Wang Y, Titmus MA, et al:
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma
and colon cancer cells. Mol Cancer. 9:962010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Boni V, Bitarte N, Cristobal I, et al:
miR-192/miR-215 influence 5-fluorouracil resistance through cell
cycle-mediated mechanisms complementary to its post-transcriptional
thymidilate synthase regulation. Mol Cancer Ther. 9:2265–2275.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wijnhoven BP, Hussey DJ, Watson DI, et al:
South Australian Oesophageal Research Group: MicroRNA profiling of
Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg.
97:853–861. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
White NM, Khella HW, Grigull J, et al:
miRNA profiling in metastatic renal cell carcinoma reveals a
tumour-suppressor effect for miR-215. Br J Cancer. 105:1741–1749.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Faltejskova P, Svoboda M, Srutova K, et
al: Identification and functional screening of microRNAs highly
deregulated in colorectal cancer. J Cell Mol Med. 16:2655–2666.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jin Z, Selaru FM, Cheng Y, et al:
MicroRNA-192 and −215 are upregulated in human gastric cancer in
vivo and suppress ALCAM expression in vitro. Oncogene.
30:1577–1585. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ueda T, Volinia S, Okumura H, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: a microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsukamoto Y, Nakada C, Noguchi T, Tanigawa
M, et al: MicroRNA-375 is downregulated in gastric carcinomas and
regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer
Res. 70:2339–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
